医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

Reddy’s Laboratories Announces the Launch

Dr. Reddy’s Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Fluphenazine Hydrochloride Tablets Market Reddy's Laboratories Announces the Launch USP in the

2021年02月18日

Dr. Reddy’s Laboratories announces the launch of Febuxostat Tablets in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Febuxostat Tablets in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Febuxostat Tablets in the Market Reddy's Laboratories Announces the Launch

2021年01月11日

Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market

ヘルスケア製薬　 TimeLine: Arthritis Pain in the Market of Over-The-Counter Diclofenac Sodium Topical Gel 1%Reddy's Laboratories Announces the Launch the store brand version of Voltaren

2020年09月09日

Dr. Reddy’s Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Market Methylphenidate Hydrochloride Extended-Release Tablets Reddy's Laboratories Announces the Launch USP

2020年09月03日

Dr. Reddy’s Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Market of Penicillamine Capsules Reddy's Laboratories Announces the Launch USP

2020年08月27日

Dr. Reddy’s Laboratories announces the launch of AVIGAN® (Favipiravir) in India

Dr. Reddy’s Laboratories announces the launch of AVIGAN® (Favipiravir) in India

ヘルスケアヘルス一般感染症製薬　 TimeLine: Avigan favipiravir Reddy's Laboratories Announces the Launch

2020年08月19日

Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette® Lozenges in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: Lozenges Market of Over-The-Counter Nicotine Polacrilex Reddy's Laboratories Announces the Launch

2020年07月14日

Dr. Reddy’s Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market

ヘルスケアヘルス一般製薬　 TimeLine: Amphetamine Sulfate Tablets Market Reddy's Laboratories Announces the Launch USP

2020年04月14日

Dr. Reddy’s Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: in the U.S Reddy's Laboratories Announces the Launch

2019年12月06日

Dr. Reddy’s Laboratories Announces the Launch of Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. Market

ヘルスケアヘルス一般病院腫瘍学製薬　 TimeLine: Reddy's Laboratories Announces the Launch vial for Intravenous Use Only in the

2019年12月04日